Bavarian Nordic lands breakthrough designation for RSV vaccine; Ucello closes Series A to advance CAR-T therapies
The FDA has granted Bavarian Nordic a Breakthrough Therapy Designation for its vaccine to prevent lower respiratory tract disease caused by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
